Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Biomaterials|August 3, 2020
Nanosized zeolites as a gas delivery platform in a glioblastoma modelClément Anfray, Sarah Komaty, Aurélien Corroyer-Dulmont, et al.Clinical Nuclear Medicine|April 29, 2022
First-in-Man Noninvasive Initial Diagnostic Approach of Primary CNS Lymphoma Versus Glioblastoma Using PET With 18 F-Fludarabine and l -[methyl- 11 C]MethionineAndrey Postnov, Jérôme Toutain, Igor Pronin, et al.Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Evaluation of a Boron-Conjugated SRC Inhibitor Combined with Proton and X-Ray Irradiation in U-87 MG and U-87 MG IDH1R132H Glioma Cell LinesCristiana Alberghina, Filippo Torrisi, Samuel Valable, et al.Neuro-Oncology|November 2, 2012
Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacyAurélien Corroyer-Dulmont, Elodie A Pérès, Edwige Petit, et al.International Journal of Particle Therapy|January 5, 2026
Radiobiology Contributions and Perspectives in Hadron Therapy, With a Focus on Carbon Ions: Report From the Workshop Hadron Therapy for Life, Caen, March 2025Siamak Haghdoost, Juliette Thariat, Iuliana Toma-Dasu, et al.Radiation Oncology (London, England)|August 5, 2025
Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective studyNicolas Goliot, Emmanuel Jouglar, Julian Jacob, et al.BMC Cancer|December 30, 2024
Proton therapy versus conventional radiotherapy for the treatment of cavernous sinus benign meningioma, a randomized controlled phase III study protocol (COG-PROTON-01)Paul Lesueur, Benedicte Clarisse, Justine Lequesne, et al.International Journal of Molecular Sciences|December 28, 2019
Hadrontherapy Interactions in Molecular and Cellular BiologyJuliette Thariat, Samuel Valable, Carine Laurent, et al.Scientific Reports|May 28, 2021
Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapyAurélien Corroyer-Dulmont, Samuel Valable, Jade Fantin, et al.The American Journal of Pathology|December 11, 2012
Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric studyIsabela J Wastowski, Renata T Simões, Layale Yaghi, et al.Pageof 11